Chemotherapy in Cutaneous Melanoma: Is There Still a Role?

PURPOSE OF REVIEW: In the preceding decade, the management of metastatic cutaneous melanoma has been revolutionised with the development of highly effective therapies including immune checkpoint inhibitors (specifically CTLA-4 and PD-1 inhibitors) and targeted therapies (BRAF and MEK inhibitors). Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, James P., Joshua, Anthony M., da Silva, Ines P., Dummer, Reinhard, Goldinger, Simone M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164011/
https://www.ncbi.nlm.nih.gov/pubmed/36988735
http://dx.doi.org/10.1007/s11912-023-01385-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164011/
https://www.ncbi.nlm.nih.gov/pubmed/36988735
http://dx.doi.org/10.1007/s11912-023-01385-6

Ejemplares similares